CK
BIIB icon

Carnick & Kubik’s Biogen BIIB Stock Holding History

Carnick & Kubik’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$52K Buy
+200
New +$52.8K 0.02% 657
2015
Q4 		– Sell
-200
Closed -$58.4K – 141
2015
Q3 		$58.4K Buy
+200
New +$66K 0.04% 195

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Carnick & Kubik's BIIB Position: Q1 2016 in Review

Carnick & Kubik opened a new position in Biogen (BIIB) in Q1 2016: 200 shares worth $52K. The stake represents 0.02% of the portfolio and ranks #657 among its holdings. This is a return to the name: Carnick & Kubik previously reported a position in BIIB as recently as Q3 2015.

Carnick & Kubik first reported a position in BIIB in Q3 2015 and has held it in 2 quarters since. The position peaked at $58.4K in Q3 2015. 947 funds tracked by Wall St. Rank hold BIIB as of Q1 2016.

  • Carnick & Kubik held 200 shares of Biogen worth $52K as of Q1 2016.
  • Biogen was a new Carnick & Kubik position in Q1 2016.
  • Biogen made up 0.02% of Carnick & Kubik's portfolio in Q1 2016, its #657 holding.
  • Carnick & Kubik first reported a position in Biogen in Q3 2015 and has held it in 2 quarters since.
  • Carnick & Kubik's Biogen position peaked at $58.4K in Q3 2015.
  • 947 funds tracked by Wall St. Rank held Biogen as of Q1 2016.

Based on Carnick & Kubik's 13F filing for Q1 2016, filed 12 May 2016.